Literature DB >> 656324

Chilblain lupus erythematosus (Hutchinson). A clinical and laboratory study of 17 patients.

L G Millard, N R Rowell.   

Abstract

Chilblain lupus erythematosus (LE) is a chronic unremitting form of LE ssen predominantly in women. It occurs commonly on the digits, calves and heels. Nasal lesions are rare. Chronic facial discoid LE usually appears before the chilblain form but, in most instances, resolves even though the chilblain lesions persists. Transformation to systemic LE occurs more often in those who develop both forms of cutaneous LE simultaneously and in the erythema multiforme syndrome. The chilblain lesions are the result of microvascular injury secondary to exposure to cold and possibly hyperviscosity from immunological abnormalities, Elevated serum gammaglobulins, positive latex factor and speckled pattern antinuclear factor are common. None of the usual treatments for cutaneous LE is effective for the chilblain lesions, probably because none is directed towards prevention and treatment of the microvascular stasis.

Entities:  

Mesh:

Year:  1978        PMID: 656324     DOI: 10.1111/j.1365-2133.1978.tb01935.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

Review 1.  Cutaneous findings in patients with primary Sjogren's syndrome.

Authors:  Mehmet Soy; Süleyman Piskin
Journal:  Clin Rheumatol       Date:  2006-08-17       Impact factor: 2.980

2.  A TREX1 mutation causing cerebral vasculopathy in a patient with familial chilblain lupus.

Authors:  Kazuo Yamashiro; Ryota Tanaka; Yuanzhe Li; Michitaka Mikasa; Nobutaka Hattori
Journal:  J Neurol       Date:  2013-08-30       Impact factor: 4.849

3.  Metastasis from carcinoma of breast masquerading as chilblains.

Authors:  B B Tan; J T Lear; J S English
Journal:  J R Soc Med       Date:  1997-03       Impact factor: 5.344

4.  Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p.

Authors:  Min Ae Lee-Kirsch; Maolian Gong; Herbert Schulz; Franz Rüschendorf; Annette Stein; Christiane Pfeiffer; Annalisa Ballarini; Manfred Gahr; Norbert Hubner; Maja Linné
Journal:  Am J Hum Genet       Date:  2006-08-17       Impact factor: 11.025

Review 5.  New roles for the major human 3'-5' exonuclease TREX1 in human disease.

Authors:  David Kavanagh; Dirk Spitzer; Parul H Kothari; Aisha Shaikh; M Kathryn Liszewski; Anna Richards; John P Atkinson
Journal:  Cell Cycle       Date:  2008-06-16       Impact factor: 4.534

Review 6.  Chilblain lupus erythematosus--a review of literature.

Authors:  C M Hedrich; B Fiebig; F H Hauck; S Sallmann; G Hahn; C Pfeiffer; G Heubner; Min Ae Lee-Kirsch; M Gahr
Journal:  Clin Rheumatol       Date:  2008-06-10       Impact factor: 2.980

7.  Chilblains in immune mediated inflammatory diseases: a review.

Authors:  Shirish Dubey; Nilay Joshi; Olivia Stevenson; Caroline Gordon; John A Reynolds
Journal:  Rheumatology (Oxford)       Date:  2022-04-12       Impact factor: 7.046

8.  Familial chilblain lupus due to a novel mutation in TREX1 associated with Aicardi-Goutie'res syndrome.

Authors:  Cuili Yi; Qiyuan Li; Jihong Xiao
Journal:  Pediatr Rheumatol Online J       Date:  2020-04-15       Impact factor: 3.054

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.